CPVL-AS2 (CPVL antisense RNA 2) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: CPVL-AS2 (CPVL antisense RNA 2) Homo sapiens
Analyze
Symbol: CPVL-AS2
Name: CPVL antisense RNA 2
RGD ID: 16566451
HGNC Page HGNC:56138
Description:
Type: ncrna (Ensembl: lncRNA)
RefSeq Status: VALIDATED
Previously known as: AC005162.2; AC005162.3; LOC100506497; novel transcript, antisense to CPVL; uncharacterized LOC100506497
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38.p14 Ensembl - Human Genome Assembly GRCh38 Ensembl
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38728,979,967 - 29,013,369 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl728,979,967 - 29,013,367 (+)EnsemblGRCh38hg38GRCh38
GRCh37729,019,583 - 29,052,985 (+)NCBIGRCh37GRCh37hg19GRCh37
Cytogenetic Map7p14.3NCBI
HuRef728,901,450 - 28,934,838 (+)NCBIHuRef
CHM1_1729,019,781 - 29,053,124 (+)NCBICHM1_1
T2T-CHM13v2.0729,117,492 - 29,150,886 (+)NCBIT2T-CHM13v2.0
JBrowse: View Region in Genome Browser (JBrowse)
Model


References
Additional References at PubMed
PMID:12477932   PMID:14702039   PMID:19734545  


Genomics

Variants

.
Variants in CPVL-AS2
1 total Variants

Clinical Variants
Name Type Condition(s) Position(s) Clinical significance
GRCh38/hg38 7p21.1-14.3(chr7:20561456-32005143)x1 copy number loss See cases [RCV000136775] Chr7:20561456..32005143 [GRCh38]
Chr7:20601079..32044755 [GRCh37]
Chr7:20567604..32011280 [NCBI36]
Chr7:7p21.1-14.3
pathogenic
GRCh38/hg38 7p22.3-14.1(chr7:54185-41875885)x3 copy number gain See cases [RCV000051159] Chr7:54185..41875885 [GRCh38]
Chr7:54185..41915483 [GRCh37]
Chr7:149268..41882008 [NCBI36]
Chr7:7p22.3-14.1
pathogenic
GRCh38/hg38 7p22.3-14.2(chr7:54185-37089712)x3 copy number gain See cases [RCV000053530] Chr7:54185..37089712 [GRCh38]
Chr7:54185..37129317 [GRCh37]
Chr7:149268..37095842 [NCBI36]
Chr7:7p22.3-14.2
pathogenic
GRCh38/hg38 7p22.3-q36.3(chr7:53985-159282531)x1 copy number loss See cases [RCV000052250] Chr7:53985..159282531 [GRCh38]
Chr7:53985..159075220 [GRCh37]
Chr7:149068..158767981 [NCBI36]
Chr7:7p22.3-q36.3
pathogenic
GRCh38/hg38 7p15.2-14.3(chr7:25511691-30421133)x1 copy number loss See cases [RCV000052310] Chr7:25511691..30421133 [GRCh38]
Chr7:25551310..30460749 [GRCh37]
Chr7:25517835..30427274 [NCBI36]
Chr7:7p15.2-14.3
pathogenic
GRCh38/hg38 7p22.3-q36.3(chr7:54185-159282390)x1 copy number loss See cases [RCV000135401] Chr7:54185..159282390 [GRCh38]
Chr7:54185..159075079 [GRCh37]
Chr7:149268..158767840 [NCBI36]
Chr7:7p22.3-q36.3
pathogenic
NM_031311.5(CPVL):c.1391G>A (p.Arg464Gln) single nucleotide variant not provided [RCV000909126] Chr7:28995812 [GRCh38]
Chr7:29035428 [GRCh37]
Chr7:7p14.3
likely benign
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:162
Count of miRNA genes:96
Interacting mature miRNAs:98
Transcripts:ENST00000608972, ENST00000609389, ENST00000609495
Prediction methods:Miranda, Rnahybrid
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


Expression


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system sensory system adipose tissue appendage entire extraembryonic component
High
Medium 6 11 2 1 6
Low 846 256 975 169 285 20 926 430 2829 234 961 857 148 472 482
Below cutoff 1470 2174 642 368 605 357 3140 1699 835 108 396 585 14 728 2157 4

Sequence


RefSeq Acc Id: ENST00000608972
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl729,008,926 - 29,010,252 (+)Ensembl
RefSeq Acc Id: ENST00000609389
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl728,979,967 - 29,013,367 (+)Ensembl
RefSeq Acc Id: ENST00000609495
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl729,000,971 - 29,010,252 (+)Ensembl
RefSeq Acc Id: ENST00000670619
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl728,980,022 - 29,013,091 (+)Ensembl
RefSeq Acc Id: NR_038965
RefSeq Status: VALIDATED
Type: NON-CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38728,979,967 - 29,013,369 (+)NCBI
T2T-CHM13v2.0729,117,492 - 29,150,886 (+)NCBI
Sequence:

Additional Information

Database Acc Id Source(s)
COSMIC CPVL-AS2 COSMIC
Ensembl Genes ENSG00000272568 Ensembl, ENTREZGENE
Ensembl Transcript ENST00000670619 ENTREZGENE
GTEx ENSG00000272568 GTEx
HGNC ID HGNC:56138 ENTREZGENE
Human Proteome Map CPVL-AS2 Human Proteome Map
NCBI Gene LOC100506497 ENTREZGENE
RNAcentral URS000075C32B RNACentral


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2022-01-17 CPVL-AS2  CPVL antisense RNA 2  AC005162.2  novel transcript, antisense to CPVL  Symbol and/or name change 19259463 PROVISIONAL
2020-06-25 AC005162.2  novel transcript, antisense to CPVL  LOC100506497  uncharacterized LOC100506497  Symbol and/or name change 19259462 PROVISIONAL
2020-06-18 LOC100506497  uncharacterized LOC100506497  AC005162.2  novel transcript, antisense to CPVL  Symbol and/or name change 5135510 APPROVED
2020-02-07 AC005162.2  novel transcript, antisense to CPVL  AC005162.3  novel transcript, antisense to CPVL  Symbol and/or name change 19259462 PROVISIONAL